TuisBOT • ASX
add
Botanix Pharmaceuticals Ltd
Vorige sluiting
$0,43
Dagwisseling
$0,40 - $0,44
Jaarwisseling
$0,21 - $0,54
Markkapitalisasie
760,80 m AUD
Gemiddelde volume
11,32 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
ASX
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (AUD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 188,80 k | -0,09% |
Bedryfskoste | 15,57 m | 532,16% |
Netto inkomste | -15,44 m | -464,98% |
Netto winsgrens | -8,18 k | -465,47% |
Wins per aandeel | — | — |
EBITDA | -15,43 m | -459,15% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (AUD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 48,44 m | 164,49% |
Totale bates | 99,45 m | 108,57% |
Totale aanspreeklikheid | 6,96 m | 203,76% |
Totale ekwiteit | 92,49 m | — |
Uitstaande aandele | 1,82 mjd | — |
Prys om te bespreek | 8,50 | — |
Opbrengs op bates | -40,19% | — |
Opbrengs op kapitaal | -42,81% | — |
Kontantvloei
Netto kontantverandering
| (AUD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -15,44 m | -464,98% |
Kontant van bedrywe | -15,28 m | -712,75% |
Kontant van beleggings | -426,99 k | 94,22% |
Kontant van finansiering | 200,20 k | -98,50% |
Netto kontantverandering | -15,44 m | -482,88% |
Beskikbare kontantvloei | -4,57 m | 45,34% |
Meer oor
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Gestig
1984
Webwerf
Werknemers
11
